SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-18-004559
Filing Date
2018-09-07
Accepted
2018-09-07 08:00:54
Documents
6
Period of Report
2018-09-28
Effectiveness Date
2018-09-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ohr-def14a_090518.htm DEF 14A 533626
2 GRAPHIC ohr001.jpg GRAPHIC 15251
3 GRAPHIC ohr002.jpg GRAPHIC 4792
4 GRAPHIC ohr003.jpg GRAPHIC 855
5 GRAPHIC ohr004.jpg GRAPHIC 832
6 GRAPHIC ohr005.jpg GRAPHIC 839
  Complete submission text file 0001387131-18-004559.txt   566536
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-35963 | Film No.: 181058906
SIC: 2834 Pharmaceutical Preparations